Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STK4 | Q13043 | 9/20 | 0.78 |
| ▸ | EGFR | P00533 | 6/20 | 0.71 |
| ▸ | ERBB2 | P04626 | 5/20 | 0.71 |
| ▸ | STK3 | Q13188 | 11/20 | 0.70 |
| ▸ | STK25 | O00506 | 1/20 | 0.65 |
| ▸ | MAP2K7 | O14733 | 1/20 | 0.65 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.65 |
| ▸ | GAK | O14976 | 1/20 | 0.65 |
| ▸ | EPHB6 | O15197 | 1/20 | 0.65 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.65 |
| ▸ | MAP3K13 | O43283 | 1/20 | 0.65 |
| ▸ | NUAK1 | O60285 | 1/20 | 0.65 |
| ▸ | STK17B | O94768 | 1/20 | 0.65 |
| ▸ | STK10 | O94804 | 1/20 | 0.65 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.65 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.65 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.65 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.65 |
| ▸ | ABL1 | P00519 | 1/20 | 0.65 |
| ▸ | INSR | P06213 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL33530218 | 0.94 | EGFR (0.81) | STK4EGFRERBB2STK3STK25 | |
| SCHEMBL2386736 | 0.94 | EGFR (0.81) | STK4EGFRERBB2STK3STK25 | |
| SCHEMBL22419656 | 0.88 | STK4 (1.00) | STK4EGFRERBB2STK3 | |
| SCHEMBL20204909 | 0.87 | EGFR (0.80) | STK4EGFRERBB2STK3STK25 | |
| SCHEMBL13826188 | 0.87 | STK3 (0.85) | STK4EGFRERBB2STK3STK25 | |
| SCHEMBL10054547 | 0.86 | STK4 (0.78) | STK4EGFRERBB2STK3STK25 | |
| SCHEMBL12309393 | 0.85 | STK4 (0.77) | STK4EGFRERBB2STK3STK25 | |
| SCHEMBL13445964 | 0.85 | EGFR (0.78) | STK4EGFRERBB2STK3STK25 | |
| SCHEMBL5493504 | 0.85 | STK4 (0.79) | STK4EGFRERBB2STK3 | |
| SCHEMBL10054548 | 0.85 | STK4 (0.76) | STK4EGFRERBB2STK3STK25 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8173814-B2 | Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof | WYETH LLC (US) | 2012-05-08 | — | — | US | disclosed |
| US-8022216-B2 | Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof | WYETH LLC (US) | 2011-09-20 | — | — | US | disclosed |
| US-20090176827-A1 | MALEATE SALTS OF (E)-N--4-(DIMETHYLAMINO)-2-BUTENAMIDE AND CRYSTALLINE FORMS THEREOF | WYETH (US) | 2009-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176827-A1 | MALEATE SALTS OF (E)-N--4-(DIMETHYLAMINO)-2-BUTENAMIDE AND CRYSTALLINE FORMS THEREOF | EGFR, ERBB4, ALK | STK4 251/4885EGFR 1/4885ERBB2 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.